Skip to main content
logo
McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
1,103.98
+34.54 (3.23%)
Nov 5, 2026, 11:02 AM EST - Market open

McKesson Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal Quarter
Q2 2027Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
110,957105,38096,295106,158103,15097,82790,82395,29493,65179,28376,35580,89877,21574,48368,91070,49070,15767,15466,10268,614
Revenue Growth
7.57%7.72%6.02%11.40%10.14%23.39%18.95%17.79%21.29%6.44%10.80%14.77%10.06%10.91%4.25%2.73%5.38%7.15%11.77%9.61%
Gross Profit
3,9563,6854,0443,6703,5423,2793,3743,2533,2483,0623,5613,1292,9902,9042,9373,1743,0953,0233,2723,428
Operating Income
1,6871,4212,1271,6401,4171,2721,2421,2255421,0611,3961,1518981,0069731,1281,1221,0261,0301,202
Net Income
1,2186141,6821,1861,1107841,2608792419157915896649587871,079926768368-7
Earnings Per Share
10.445.1513.739.598.926.2510.016.951.877.006.014.424.927.025.697.666.425.262.46-0.05
EPS Growth
17.04%-17.60%37.18%37.99%377.00%-10.71%66.36%57.24%-61.99%-0.29%5.62%-42.28%-23.34%33.37%131.27%-275.34%71.40%-40.57%-

Revenue by Segment
Chart
Fiscal Quarter
Q2 2027Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
North American Pharmaceutical
91,36086,77379,12088,32286,48182,72976,94381,19880,01866,348----------
Oncology & Multispecialty
14,98014,22212,71113,01012,04410,6589,4319,4939,1578,781----------
Prescription Technology Solutions
1,5201,5661,4951,5001,3761,4341,3391,3711,2651,2411,1801,2051,1401,2441,1821,1211,0181,0661,0201,031
Medical Surgical Solutions
3,0972,8192,8682,9912,9472,7012,8532,9492,9462,6322,8373,0312,8342,6112,6892,9862,8432,5922,8743,082
Other Segment
00101335302305257283265281----------
Revenue (Total)
110,957105,38096,295106,158103,15097,82790,82395,29493,65179,28376,35580,89877,21574,48368,91070,49070,15767,15466,10268,614

Cash & Debt
Chart
Fiscal Quarter
Q2 2027Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Investments
6,5285,1643,9752,9594,0042,4185,6911,1312,5092,3024,5831,9822,5242,6364,6782,7742,9162,2333,5632,754
Total Debt
11,16111,7968,7868,7359,95510,1967,4329,7907,2557,4367,4267,6407,3687,4767,3138,2227,3087,4327,6178,099
Net Cash (Debt)
-4,633-6,632-4,811-5,776-5,951-7,778-1,741-8,659-4,746-5,134-2,843-5,658-4,844-4,840-2,635-5,448-4,392-5,199-4,054-5,345
Net Cash Growth
--------------------
Net Cash Per Share
-39.70-55.64-39.21-46.69-47.84-61.98-13.83-68.40-36.71-39.28-21.60-42.45-35.93-35.43-19.09-38.64-30.48-35.63-27.17-35.26

Cash Flow & CapEx
Chart
Fiscal Quarter
Q2 2027Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Cash Flow
3,070-2203,4211,2322,420-9187,748-2,3832,100-1,3804,147254965-1,0523,3251,6681,107-9412,8871,377
Capital Expenditures
-65-112-111-108-106-111-169-126-136-106-188-90-75-78-125-108-86-71-135-67
Free Cash Flow
3,005-3323,3101,1242,314-1,0297,579-2,5091,964-1,4863,959164890-1,1303,2001,5601,021-1,0122,7521,310
Free Cash Flow Growth
29.86%--56.33%-17.82%-91.44%-120.67%-23.72%-89.49%-12.83%-16.28%19.08%-39.91%--14.32%19.74%

Margins
Chart
Fiscal Quarter
Q2 2027Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Gross Margin
3.56%3.50%4.20%3.46%3.43%3.35%3.72%3.41%3.47%3.86%4.66%3.87%3.87%3.90%4.26%4.50%4.41%4.50%4.95%5.00%
Operating Margin
1.52%1.35%2.21%1.54%1.37%1.30%1.37%1.29%0.58%1.34%1.83%1.42%1.16%1.35%1.41%1.60%1.60%1.53%1.56%1.75%
Pretax Margin
1.41%1.24%2.21%1.54%1.35%1.07%1.67%1.29%0.57%1.37%1.53%0.76%1.19%1.46%1.35%2.05%1.77%1.50%0.98%0.40%
Profit Margin
1.10%0.58%1.75%1.12%1.08%0.80%1.39%0.92%0.26%1.15%1.04%0.73%0.86%1.29%1.14%1.53%1.32%1.14%0.56%-0.01%
FCF Margin
2.71%-0.32%3.44%1.06%2.24%-1.05%8.34%-2.63%2.10%-1.87%5.18%0.20%1.15%-1.52%4.64%2.21%1.46%-1.51%4.16%1.91%

Dividends
Chart
Fiscal Quarter
Q2 2027Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Dividend Per Share
-0.8200.8200.8200.8200.7100.7100.7100.7100.6200.6200.6200.6200.5400.5400.5400.5400.4700.4700.470
Dividend Per Share Growth
-15.49%15.49%15.49%15.49%14.52%14.52%14.52%14.52%14.82%14.82%14.82%14.82%14.89%14.89%14.89%14.89%11.91%11.91%11.91%
Dividend Yield
-0.43%0.36%0.37%0.38%0.39%0.41%0.46%0.51%0.43%0.44%0.50%0.51%0.50%0.58%0.52%0.57%0.58%0.58%0.70%

Valuation
Chart
Fiscal Quarter
Q2 2027Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
21.1819.2722.2623.3323.8328.9325.6025.6025.2825.6023.5020.5516.8215.4413.7016.9323.7733.5541.17-
Forward PE
18.3517.0719.9919.9119.4419.6218.4716.4515.3318.4518.4716.2215.9916.0713.5914.8113.8314.0013.4411.43
P/FCF Ratio
14.01-18.5310.1415.12-15.20-13.94-18.1719.7212.98-10.2212.3112.00-11.338.42
PS Ratio
0.240.220.260.250.250.240.240.210.190.240.230.200.200.200.180.190.180.170.170.15